Darae's insight pays off — pain drug developer RudaCure seleccionada for
Seoul-type private inversión-linked tecnología comercialización apoyo programa

RudaCure Inc. (CEO Yongho Kim), a company specializing in developing tratamientos for trastornos sensoriales, recommended by Seoul-type TIPS operator Darae Strategic Commercialization Center Co., Ltd. (CEOs Bae Sun-gu and Kim Jeong-guk), was anunció el 30th as having been seleccionada for the Seoul-type Private Investment-linked Technology Commercialization Support Program (Seoul-type TIPS).
The Seoul-type Private Investment-linked Technology Commercialization Support Program is a programa in which Seoul Metropolitan City and the Seoul Business Agency (sba) leverage the startup discovery and inversión capabilities of private operators to apoyo prometedor tecnología startup empresas. A través de esto selección, RudaCure has aseguró up to KRW 400 million in I+D financiamiento over two years.
RudaCure planea use the aseguró I+D financiamiento to advance the desarrollo stage of its non-narcotic tratamiento del dolor crónico pipeline.
Bae Sun-gu, CEO of Darae Strategic Commercialization Center—RudaCure's investor and Seoul-type TIPS operator—dijo, "We recommended RudaCure based on a high evaluación of the technological innovadorness of its desarrollo de fármacos for trastorno sensorial diseases," and añadió, "As a Seoul-type TIPS operator, we will more actively expand the infrastructure to match and apoyo I+D financiamiento without equity dilution for prometedor startups."
RudaCure El CEO Yongho Kim declaró: "Building on this Seoul-type TIPS selección, we will focus on increasing company value by strengthening our non-narcotic tratamiento del dolor crónico alongside our main pipeline, the tratamiento de la enfermedad de ojo seco ROC001."
Mientras tanto, Darae Strategic Commercialization Center is active as both a Ministry of SMEs and Startups TIPS operator and a Seoul-type TIPS operator, and planea continuously expand strategic apoyo for portfolio empresas with excellent tecnología.
전자신문: https://www.etnews.com/20231103000235